CRT Boosts Survival in High-Risk Endometrial Cancer

Adjuvant chemoradiotherapy improves 10-year overall and recurrence-free survival for patients with high-risk endometrial cancer, but benefits vary by molecular class. Medscape Medical News

Read the full article on medscape.com